That's cute :) Leronlimab is not at the forefron
Post# of 148179
(Total Views: 543)
Posted On: 08/19/2020 12:10:04 AM
That's cute 
Leronlimab is not at the forefront of therapeutics because aside from a small handful of investors (some very long time supporters of the company), the general medical world has no idea about the monoclonal antibody or the company that makes it. Being at the forefront would give us a shareprice far greater than what we currently have.
Hopefully the above changes this week with emergency use approval by the FDA in the US or any other country that is smart enough to understand what CYDY has here.
Leronlimab is not at the forefront of therapeutics because aside from a small handful of investors (some very long time supporters of the company), the general medical world has no idea about the monoclonal antibody or the company that makes it. Being at the forefront would give us a shareprice far greater than what we currently have. Hopefully the above changes this week with emergency use approval by the FDA in the US or any other country that is smart enough to understand what CYDY has here.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼